TY - JOUR
T1 - Predictors for Surgical Referral in Patients with Pancreatic Cystic Lesions Undergoing Endoscopic Ultrasound
T2 - Results from a Large Multicenter Cohort Study
AU - Ge, Phillip S.
AU - Gaddam, Srinivas
AU - Keach, Joseph W.
AU - Mullady, Daniel
AU - Fukami, Norio
AU - Edmundowicz, Steven A.
AU - Azar, Riad R.
AU - Shah, Raj J.
AU - Murad, Faris M.
AU - Kushnir, Vladimir M.
AU - Ghassemi, Kourosh F.
AU - Sedarat, Alireza
AU - Watson, Rabindra R.
AU - Amateau, Stuart K.
AU - Brauer, Brian C.
AU - Yen, Roy D.
AU - Hosford, Lindsay
AU - Hollander, Thomas
AU - Donahue, Timothy R.
AU - Schulick, Richard D.
AU - Edil, Barish H.
AU - McCarter, Martin D.
AU - Gajdos, Csaba
AU - Attwell, Augustin R.
AU - Muthusamy, V. Raman
AU - Early, Dayna S.
AU - Wani, Sachin
N1 - Publisher Copyright:
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Objective Endoscopic ultrasound (EUS) plays an integral role in the evaluation of pancreatic cysts lesions (PCLs). The aim of the study was to determine predictors of surgical referral in patients with PCLs undergoing EUS. Methods We performed a multicenter retrospective study of patients undergoing EUS for evaluation of PCLs. Demographics, EUS characteristics, and fine-needle aspiration results were recorded. Patients were categorized into surgery or surveillance groups on the basis of post-EUS recommendations. Univariate and multivariate analyses were performed to identify predictors of surgical referral. Results 1804 patients were included. 1301 patients were recommended to undergo surveillance and 503 patients were referred for surgical evaluation, of which 360 patients underwent surgery. Multivariate analysis revealed the following 5 independent predictors of surgical referral: symptoms of weight loss on presentation (odds ratio [OR], 2.69; 95% confidence interval [CI], 1.44-5.03), EUS findings of associated solid mass (OR, 7.34; 95% CI, 3.81-14.16), main duct communication (OR, 4.13; 95% CI, 1.71-9.98), multilocular macrocystic morphology (OR, 2.79; 95% CI, 1.78-4.38), and fine-needle aspiration findings of mucin on cytology (OR, 3.06; 95% CI, 1.94-4.82). Conclusions This study identifies factors associated with surgical referral in patients with PCLs undergoing EUS. Future studies should focus on creation of risk stratification models to determine the need for surgery or enrollment in surveillance programs.
AB - Objective Endoscopic ultrasound (EUS) plays an integral role in the evaluation of pancreatic cysts lesions (PCLs). The aim of the study was to determine predictors of surgical referral in patients with PCLs undergoing EUS. Methods We performed a multicenter retrospective study of patients undergoing EUS for evaluation of PCLs. Demographics, EUS characteristics, and fine-needle aspiration results were recorded. Patients were categorized into surgery or surveillance groups on the basis of post-EUS recommendations. Univariate and multivariate analyses were performed to identify predictors of surgical referral. Results 1804 patients were included. 1301 patients were recommended to undergo surveillance and 503 patients were referred for surgical evaluation, of which 360 patients underwent surgery. Multivariate analysis revealed the following 5 independent predictors of surgical referral: symptoms of weight loss on presentation (odds ratio [OR], 2.69; 95% confidence interval [CI], 1.44-5.03), EUS findings of associated solid mass (OR, 7.34; 95% CI, 3.81-14.16), main duct communication (OR, 4.13; 95% CI, 1.71-9.98), multilocular macrocystic morphology (OR, 2.79; 95% CI, 1.78-4.38), and fine-needle aspiration findings of mucin on cytology (OR, 3.06; 95% CI, 1.94-4.82). Conclusions This study identifies factors associated with surgical referral in patients with PCLs undergoing EUS. Future studies should focus on creation of risk stratification models to determine the need for surgery or enrollment in surveillance programs.
KW - CEA - carcinoembryonic antigen
KW - EUS - endoscopic ultrasound
KW - FNA - fine-needle aspiration
KW - IPMN - intraductal papillary mucinous neoplasm
KW - IQR - interquartile range
KW - Key Words/Abbreviations
KW - MCN - mucinous cystic neoplasm
KW - NMCN - nonmucinous cystic neoplasm
KW - PCL - pancreatic cystic lesion
KW - SD - standard deviation
KW - endoscopic ultrasound
KW - intraductal papillary mucinous neoplasms
KW - mucinous cystic neoplasms
KW - pancreatic cystic lesions
KW - pancreatic cysts
KW - surgical predictors
UR - http://www.scopus.com/inward/record.url?scp=84952673519&partnerID=8YFLogxK
U2 - 10.1097/MPA.0000000000000386
DO - 10.1097/MPA.0000000000000386
M3 - Article
C2 - 26262589
AN - SCOPUS:84952673519
SN - 0885-3177
VL - 45
SP - 51
EP - 57
JO - Pancreas
JF - Pancreas
IS - 1
ER -